6月11日中欧医疗健康混合C净值下跌0.80%，近6个月累计上涨4.62%

Group 1 - The core viewpoint of the news is the performance and holdings of the China Europe Medical Health Mixed Fund C, which has shown a recent decline in net value but positive returns over various time frames [1] - As of June 11, 2025, the latest net value of the fund is 1.6776 yuan, reflecting a decrease of 0.80%. The fund's one-month return is 10.84%, ranking 194 out of 4655 in its category. Over three months, the return is 10.66%, ranking 282 out of 4602, and year-to-date, the return is 11.21%, ranking 813 out of 4536 [1] - The top ten stock holdings of the fund account for a total of 55.30%, with significant positions in companies such as Heng Rui Pharmaceutical (10.60%), WuXi AppTec (9.95%), and Mindray Medical (5.21%) [1] Group 2 - The China Europe Medical Health Mixed Fund C was established on September 29, 2016, and as of March 31, 2025, it has a total scale of 15.566 billion yuan. The fund manager is Ms. Ge Lan [1] - Ms. Ge Lan has a background in biomedical engineering with a Ph.D. from Northwestern University in the United States. She has held various research and fund management positions before becoming the fund manager of the China Europe Medical Health Mixed Fund C [2]